VEXRX
Price
$112.23
Change
-$0.07 (-0.06%)
Updated
Jan 22 closing price
Net Assets
22.07B
WAMVX
Price
$4.29
Change
-$0.02 (-0.46%)
Updated
Jan 22 closing price
Net Assets
356.16M
Ad is loading...

VEXRX vs WAMVX

Header iconVEXRX vs WAMVX Comparison
Open Charts VEXRX vs WAMVXBanner chart's image
Vanguard Explorer Adm
Price$112.23
Change-$0.07 (-0.06%)
VolumeN/A
Net Assets22.07B
Wasatch Micro Cap Value
Price$4.29
Change-$0.02 (-0.46%)
VolumeN/A
Net Assets356.16M
VEXRX vs WAMVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VEXRX vs. WAMVX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEXRX is a Hold and WAMVX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 22.1B vs. WAMVX (356M). VEXRX pays higher dividends than WAMVX: VEXRX (0.58) vs WAMVX (0.00). VEXRX was incepted earlier than WAMVX: VEXRX (23 years) vs WAMVX (22 years). WAMVX is a more actively managed with annual turnover of: 59.00 vs. VEXRX (40.00). WAMVX has a lower initial minimum investment than VEXRX: WAMVX (2000) vs VEXRX (50000). WAMVX annual gain was more profitable for investors over the last year : 30.00 vs. VEXRX (10.04). WAMVX return over 5 years is better than : 28.06 vs. VEXRX (14.59).
VEXRXWAMVXVEXRX / WAMVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years22 years-
Gain YTD5.0352.632191%
Front LoadN/AN/A-
Min. Initial Investment5000020002,500%
Min. Initial Investment IRAN/AN/A-
Net Assets22.1B356M6,208%
Annual Yield % from dividends0.580.00-
Returns for 1 year10.0430.0033%
Returns for 3 years8.1115.9551%
Returns for 5 years14.5928.0652%
Returns for 10 years32.2758.0556%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCAYX57.140.26
+0.46%
Hartford Capital Appreciation Y
NEQCX12.150.02
+0.16%
Neuberger Berman U.S. Equity Impact C
MGINX10.27N/A
N/A
DWS Global Macro Inst
MCSSX39.46-0.08
-0.20%
NYLI WMC Enduring Capital Investor Class
FBTTX24.11-0.13
-0.54%
Fidelity Advisor Biotechnology M